Authors

Darren J Creek

BPharm (Hons), PhD, MPS, Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Vic


Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine

There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19.